drug
fosfomycin disodium
Marketedupdated 3mo agoby Meitheal Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(1)
Trials studying fosfomycin disodium
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 22, 2028
~2.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Jan 30, 2039method-of-use (U-4331)US 11541064
- Oct 27, 2034method-of-use (U-4332)US 9345717
- Oct 12, 2034method-of-use (U-4332)US 10086006
FDA exclusivities (2)
- Oct 22, 2033GAINGAIN Antibiotic (5y)
- Oct 22, 2028NPNP2.2y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that